VC Stock Cash Flow Statements

Visteon Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Visteon Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2010-12-31	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2007-12-31	2006-12-31	2006-09-30	2005-12-31	2004-12-31	2003-12-31	2002-12-31

operating activities
net income	69,000,000	67,000,000	125,000,000	40,000,000	75,000,000	44,000,000	373,000,000	71,000,000	23,000,000	38,000,000	35,000,000	49,000,000	23,000,000	23,000,000	35,000,000	7,000,000	-11,000,000	19,000,000	20,000,000	10,000,000	-42,000,000	-36,000,000	39,000,000	18,000,000	8,000,000	16,000,000	45,000,000	24,000,000	36,000,000	69,000,000	30,000,000	47,000,000	48,000,000	67,000,000	6,000,000	32,000,000	30,000,000	23,000,000	24,000,000	10,000,000	2,224,000,000	70,000,000	-114,000,000	1,000,000	-141,000,000	48,000,000	545,000,000	60,000,000	86,000,000	84,000,000	34,000,000	84,000,000	-11,000,000	-6,000,000	60,000,000	157,000,000	248,000,000	297,000,000	-23,000,000	-99,000,000	9,000,000	-43,000,000	-39,000,000	-177,000,000	1,338,000,000
adjustments to reconcile net income to net cash provided from operating activities:
depreciation and amortization	27,000,000	25,000,000	25,000,000	25,000,000	24,000,000	22,000,000	25,000,000	24,000,000	26,000,000	29,000,000	29,000,000	27,000,000	25,000,000	27,000,000	26,000,000	27,000,000	28,000,000	27,000,000	29,000,000	25,000,000	25,000,000	25,000,000	26,000,000	25,000,000	24,000,000	25,000,000	24,000,000	22,000,000	23,000,000	22,000,000	25,000,000	21,000,000	22,000,000	19,000,000	22,000,000	21,000,000	20,000,000	21,000,000	22,000,000	20,000,000	59,000,000	68,000,000	65,000,000	75,000,000	64,000,000	66,000,000	62,000,000	68,000,000	65,000,000	67,000,000	64,000,000	67,000,000	65,000,000	68,000,000	86,000,000	-134,000,000	73,000,000	97,000,000	93,000,000	84,000,000	78,000,000	126,000,000	115,000,000	107,000,000	122,000,000
non-cash stock-based compensation	12,000,000	11,000,000	10,000,000	10,000,000	11,000,000	10,000,000	8,000,000	9,000,000	9,000,000	8,000,000	7,000,000	6,000,000	8,000,000	5,000,000	5,000,000	4,000,000	5,000,000	4,000,000	5,000,000	4,000,000	4,000,000	5,000,000	3,000,000	3,000,000	6,000,000	5,000,000	4,000,000			-6,000,000	3,000,000	3,000,000	4,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	1,000,000	1,000,000	3,000,000	3,000,000
equity in net income (income) of non-consolidated affiliates, net of dividends remitted	-2,000,000	-2,000,000		3,000,000	0	4,000,000		1,000,000	2,000,000	5,000,000			-1,000,000	-3,000,000
other non-cash items	-3,000,000	-1,000,000	-1,000,000	3,000,000	4,000,000	3,000,000	-3,000,000	1,000,000	-2,000,000	-2,000,000	1,000,000			1,000,000	10,000,000	1,000,000	2,000,000	1,000,000	6,000,000	-1,000,000	-4,000,000	6,000,000	3,000,000	0			1,000,000	0			13,000,000	-1,000,000	0	3,000,000	9,000,000	14,000,000			2,000,000	1,000,000			-3,000,000	7,000,000			8,000,000	3,000,000			-9,000,000	17,000,000	25,000,000	9,000,000	10,000,000		11,000,000	26,000,000	-12,000,000	0	-6,000,000	0	3,000,000	7,000,000
changes in assets and liabilities:
accounts receivable	21,000,000	-24,000,000	116,000,000	-6,000,000	-52,000,000	3,000,000	32,000,000	-12,000,000	6,000,000	-13,000,000	88,000,000	-170,000,000	-80,000,000	6,000,000	-128,000,000	-1,000,000	47,000,000	4,000,000	13,000,000	-132,000,000	68,000,000	102,000,000	-50,000,000	-1,000,000	15,000,000	3,000,000	-38,000,000	-3,000,000	37,000,000	48,000,000	-19,000,000	21,000,000	47,000,000	-39,000,000	-34,000,000	-12,000,000	51,000,000	-24,000,000	8,000,000	11,000,000	44,000,000	-62,000,000	-126,000,000	83,000,000	12,000,000	-90,000,000	-43,000,000	109,000,000	-45,000,000	-42,000,000	33,000,000	11,000,000	-102,000,000	26,000,000	63,000,000	26,000,000	-95,000,000		-103,000,000	-54,000,000	15,000,000			22,000,000
inventories	24,000,000	-20,000,000	24,000,000	0	28,000,000	-51,000,000	29,000,000	6,000,000	22,000,000	-5,000,000	7,000,000	-50,000,000	9,000,000	-71,000,000	-10,000,000	-47,000,000	-18,000,000	-17,000,000	-7,000,000	10,000,000	11,000,000	-16,000,000	26,000,000	-10,000,000	8,000,000	-11,000,000	39,000,000	-24,000,000	-8,000,000	-6,000,000	12,000,000	-7,000,000	0	-8,000,000	15,000,000	10,000,000	-4,000,000	9,000,000	9,000,000	3,000,000	-3,000,000	-29,000,000	6,000,000	-15,000,000	0	-18,000,000	25,000,000	-31,000,000	8,000,000	-51,000,000	-22,000,000	-11,000,000	-21,000,000	17,000,000	-10,000,000	80,000,000	-38,000,000	27,000,000	-18,000,000	21,000,000	3,000,000	45,000,000	44,000,000	30,000,000
accounts payable	-11,000,000	51,000,000	-35,000,000	-5,000,000	-29,000,000	37,000,000	-76,000,000	35,000,000	-30,000,000	-59,000,000	-27,000,000	175,000,000	-27,000,000	25,000,000	96,000,000	-2,000,000	-68,000,000	2,000,000	-24,000,000	160,000,000	-107,000,000	-42,000,000	24,000,000	29,000,000	11,000,000	9,000,000	-2,000,000	-9,000,000	-38,000,000	30,000,000	-15,000,000	-19,000,000	-38,000,000	18,000,000	35,000,000	-28,000,000	-21,000,000	4,000,000	-15,000,000	16,000,000	-78,000,000	110,000,000	80,000,000	-79,000,000	-110,000,000	131,000,000	64,000,000	-150,000,000	-7,000,000	190,000,000	-23,000,000	-62,000,000	126,000,000	-12,000,000	-98,000,000	119,000,000	49,000,000	29,000,000	114,000,000	58,000,000	-122,000,000	-24,000,000	99,000,000	-30,000,000
other assets and other liabilities	-42,000,000	-37,000,000	-20,000,000	35,000,000	-4,000,000	-3,000,000	16,000,000	-8,000,000	5,000,000	-20,000,000	20,000,000	35,000,000	-7,000,000	-38,000,000	29,000,000	-16,000,000	5,000,000	-29,000,000	30,000,000	36,000,000	8,000,000	-18,000,000	-7,000,000	-6,000,000	-14,000,000	-43,000,000	27,000,000	-25,000,000	-9,000,000	-70,000,000	5,000,000	-15,000,000	17,000,000	-64,000,000	31,000,000	-27,000,000	-1,000,000	-51,000,000	29,000,000	12,000,000	24,000,000	1,000,000	52,000,000	-14,000,000	-15,000,000	-44,000,000	-146,000,000	-12,000,000	-31,000,000	-34,000,000	48,000,000	-26,000,000	-21,000,000
net cash provided from operating activities	95,000,000	70,000,000	203,000,000				98,000,000											11,000,000	71,000,000			25,000,000	65,000,000	57,000,000	57,000,000	4,000,000	97,000,000	-19,000,000			86,000,000	45,000,000			82,000,000	24,000,000			64,000,000	70,000,000	31,000,000	173,000,000	104,000,000	53,000,000	31,000,000	96,000,000	133,000,000	21,000,000	36,000,000	122,000,000	156,000,000			120,000,000	35,000,000								239,000,000	-34,000,000
investing activities
capital expenditures, including intangibles	-31,000,000	-35,000,000	-41,000,000	-28,000,000	-31,000,000	-37,000,000	-43,000,000	-31,000,000	-30,000,000	-21,000,000	-27,000,000	-18,000,000	-15,000,000	-21,000,000	-16,000,000	-21,000,000	-15,000,000	-18,000,000	-21,000,000	-18,000,000	-21,000,000	-44,000,000	-33,000,000	-38,000,000	-34,000,000	-37,000,000	-31,000,000	-27,000,000	-25,000,000	-44,000,000	-30,000,000
acquisition of business, net of cash acquired
loan provided to non-consolidated affiliate			0	0
other	-1,000,000	2,000,000	1,000,000	1,000,000			0	1,000,000	1,000,000	1,000,000		1,000,000	0	1,000,000	-3,000,000	3,000,000	1,000,000	1,000,000	-1,000,000	-9,000,000	5,000,000	1,000,000	1,000,000	0	1,000,000	1,000,000	0	15,000,000	-3,000,000	1,000,000	0	4,000,000	0	-3,000,000					-1,000,000	3,000,000	13,000,000	-8,000,000	0	-4,000,000	-1,000,000	-3,000,000					0			20,000,000	-2,000,000											16,000,000	8,000,000	2,000,000
net cash used by investing activities	-82,000,000	-33,000,000	-41,000,000	-76,000,000	-35,000,000	-37,000,000	-43,000,000	-31,000,000	-29,000,000	-20,000,000	-24,000,000	-13,000,000	-10,000,000	-21,000,000	-13,000,000	-19,000,000	-16,000,000	-15,000,000	-21,000,000	-20,000,000	-16,000,000	-41,000,000	-32,000,000	-29,000,000	-33,000,000	-34,000,000		-1,000,000	-25,000,000	-41,000,000												-70,000,000		-390,000,000	-51,000,000	-20,000,000			-29,000,000	-46,000,000		29,000,000	-53,000,000	-144,000,000	-66,000,000	-1,000,000	-24,000,000	-30,000,000	-28,000,000	-31,000,000	-34,000,000	-98,000,000	-84,000,000	-81,000,000
financing activities
principal repayment of term debt facility	-5,000,000	-4,000,000	-5,000,000	-4,000,000	-5,000,000	-4,000,000	-5,000,000	-4,000,000
dividends to non-controlling interests	-14,000,000	-4,000,000						-12,000,000																																											-1,000,000
repurchase of common stock	0	-7,000,000	-43,000,000	0	0	-20,000,000	-30,000,000	-46,000,000											0	0	0	-16,000,000	0	0			-50,000,000	-50,000,000	0	-200,000,000	-30,000,000	-10,000,000	-35,000,000	-125,000,000	0	0	0	-500,000,000	0	0			0	0
stock based compensation tax withholding payments	-1,000,000	-6,000,000	0	0	0	-7,000,000	0	-1,000,000																			0				0	0	0	-1,000,000	0	0	0	-11,000,000
proceeds from the exercise of stock options	0	3,000,000					0	4,000,000
net cash used by financing activities	-20,000,000	-18,000,000	-60,000,000	-4,000,000	-5,000,000	-31,000,000	-37,000,000	-62,000,000	-52,000,000	-5,000,000				-4,000,000	-3,000,000				2,000,000				-14,000,000	-12,000,000	-21,000,000	-2,000,000	-41,000,000	-61,000,000	-3,000,000	-230,000,000	-36,000,000	-26,000,000	-54,000,000	-117,000,000	-2,000,000	-2,000,000	-10,000,000	-2,248,000,000	-15,000,000	10,000,000	-763,000,000	-6,000,000	-15,000,000				-115,000,000				-13,000,000			3,000,000		153,000,000	-11,000,000		-10,000,000	5,000,000	-240,000,000
effect of exchange rate changes on cash	20,000,000	13,000,000	-29,000,000	27,000,000	-16,000,000	-12,000,000	15,000,000			8,000,000	19,000,000	-18,000,000	-19,000,000	-4,000,000		-5,000,000	4,000,000	-10,000,000		9,000,000	2,000,000	-5,000,000						-5,000,000	-15,000,000	7,000,000																								-14,000,000	-44,000,000	0	-3,000,000	2,000,000	19,000,000	29,000,000	-27,000,000	8,000,000	8,000,000	2,000,000	1,000,000	30,000,000	12,000,000	10,000,000
net increase in cash, equivalents, and restricted cash	13,000,000	32,000,000	73,000,000
cash, equivalents, and restricted cash at beginning of the period	0	626,000,000	0	0	0	518,000,000	0	0	0	523,000,000	0	0	0	455,000,000	0	0	0	500,000,000
cash, equivalents, and restricted cash at end of the period	13,000,000	658,000,000	73,000,000	45,000,000	1,000,000	507,000,000	33,000,000	26,000,000	-28,000,000	487,000,000	158,000,000	40,000,000	-80,000,000	405,000,000	54,000,000	-69,000,000	-16,000,000	486,000,000
december 31, 2024	0	1,000,000
other comprehensive income
stock-based compensation																																												1,000,000	3,000,000	3,000,000	1,000,000	3,000,000	5,000,000	6,000,000
share repurchase
march 31, 2025	0	1,000,000
dividends to non-controlling interest
june 30, 2025
equity in net income of non-consolidated affiliates, net of dividends remitted																			-1,000,000	-2,000,000	-1,000,000	-1,000,000	1,000,000	-1,000,000	-3,000,000	-3,000,000	-3,000,000	-3,000,000	-4,000,000	-3,000,000		-1,000,000	-3,000,000	-2,000,000		1,000,000					0	-2,000,000			7,000,000	-2,000,000	85,000,000	-29,000,000	-41,000,000	-41,000,000	27,000,000	-92,000,000	-42,000,000	-34,000,000	-5,000,000	46,000,000	-29,000,000	8,000,000	-26,000,000	-13,000,000	-7,000,000	19,000,000	-5,000,000	-7,000,000
impairments											1,000,000	0	0	4,000,000
u.s. deferred tax benefit
acquisition of businesses, net of cash acquired																											0																-3,000,000
net investment hedge transactions
loan repayment from non-consolidated affiliate
borrowings on term debt facility
payments on term debt facility
short-term debt									0	3,000,000	0	0	0	-4,000,000	-2,000,000	0							-11,000,000	-5,000,000	-1,000,000	-2,000,000	25,000,000	3,000,000	-4,000,000	-12,000,000	2,000,000	1,000,000	-8,000,000	15,000,000		-1,000,000			3,000,000	5,000,000	4,000,000	-10,000,000	-3,000,000	7,000,000	39,000,000	-4,000,000	-62,000,000	-1,000,000	31,000,000	12,000,000	-2,000,000			6,000,000	2,000,000	15,000,000		5,000,000	-5,000,000	-4,000,000	-15,000,000	3,000,000	-36,000,000	9,000,000
dividends paid to non-controlling interests										-8,000,000					-2,000,000	-32,000,000			0	0	0	-7,000,000	-2,000,000				-16,000,000	-11,000,000	0	-1,000,000	-9,000,000	-18,000,000							-24,000,000	0	-28,000,000	-3,000,000	-13,000,000	-39,000,000	-29,000,000	-16,000,000	0	0
supplemental disclosures:
cash paid for interest
cash paid for income taxes, net of refunds
december 31, 2021											0	0	0	1,000,000
cash dividends																																																																		-7,000,000	-7,000,000	-7,000,000
december 31, 2022							0	0	0	1,000,000
shares repurchase
december 31, 2023			0	0	0	1,000,000
dividends payable
acquisition of non-controlling interest
tax valuation allowance benefit
contributions to equity method investments							0				-2,000,000	0	0	-1,000,000	-2,000,000	-1,000,000
march 31, 2024				0	0	1,000,000
june 30, 2024				0
september 30, 2024
adjustments to reconcile net income to net cash provided from (used by) operating activities:
net cash provided from (used by) operating activities					57,000,000	69,000,000																								81,000,000																							19,000,000			-69,000,000	40,000,000
net decrease in cash, equivalents, and restricted cash					1,000,000	-11,000,000		26,000,000	-28,000,000	-36,000,000		40,000,000	-80,000,000	-50,000,000
u.s. tax valuation allowance benefit
december 31, 2020															0	0	0	1,000,000
settlement of derivative contracts												4,000,000
march 31, 2023								0	0	1,000,000
june 30, 2023								0
september 30, 2023
net cash used by operating activities										-19,000,000																								-10,000,000																											-275,000,000
gain on sale of investment
foreign currency translation charge
proceeds from sale of investment
loan repayments from non-consolidated affiliates															4,000,000	0	0	2,000,000		0	0	2,000,000		9,000,000	0	2,000,000			0	2,000,000
borrowings on debt
principal payments on debt																															0	0	0	-2,000,000	0	-1,000,000	0	-1,000,000	0	0	-247,000,000	-3,000,000	-2,000,000				-1,000,000	0	-4,000,000	-1,000,000	-820,000,000	0	-4,000,000	0	-7,000,000	38,000,000	-12,000,000	-54,000,000	0	-74,000,000	-45,000,000	-30,000,000	-12,000,000	-2,000,000
payment of debt fees
december 31, 2019																			0	0	0	1,000,000
repurchase of shares of common stock
net cash (used by) provided from operating activities												74,000,000	-51,000,000	-21,000,000																								-58,000,000
net cash (used by) provided from financing activities												-3,000,000																																	-316,000,000	-20,000,000							-2,000,000
march 31, 2022												0	0	1,000,000
june 30, 2022												0
september 30, 2022
dividends declared to non-controlling interest
effect of exchange rates
december 31, 2018																							0	0	0	1,000,000
borrowings on revolving credit facility																				0	0	400,000,000
payments on revolving credit facility
dividends declared to non-controlling interests
march 31, 2021																0	0	1,000,000
june 30, 2021																0
september 30, 2021
net cash provided from financing activities
net increase in cash																		-14,000,000			-66,000,000	356,000,000
transaction gains
loans to non-consolidated affiliate, net of repayments
distribution payments																											0	0	0	-14,000,000	0	0	0	-1,000,000	0	0	0	-1,736,000,000
stock-based compensation tax withholding payments
december 31, 2017
business acquisition
net investment hedge
short-term debt repayments																				-23,000,000
net decrease in cash																								8,000,000	3,000,000	-32,000,000		-86,000,000	2,000,000	-183,000,000
cash and restricted cash at beginning of the period																				0	0	469,000,000		0	0	467,000,000
cash and restricted cash at end of the period																				-324,000,000	-66,000,000	825,000,000		8,000,000	3,000,000	435,000,000
march 31, 2020																				0	0	1,000,000
june 30, 2020																				0
september 30, 2020
net cash provided from (used by) financing activities																					-14,000,000	377,000,000																											6,000,000	90,000,000													154,000,000	17,000,000
other comprehensive loss
losses on divestitures and impairments																																		1,000,000		2,000,000	1,000,000	1,000,000
payments on divestiture of businesses
proceeds from asset sales and business divestitures																															0	2,000,000	3,000,000	10,000,000	2,000,000	11,000,000						3,000,000	2,000,000	4,000,000	25,000,000	35,000,000
effect of exchange rate changes on cash and equivalents																															2,000,000	4,000,000	7,000,000	6,000,000	-17,000,000	2,000,000	-3,000,000	7,000,000	-7,000,000	-4,000,000	8,000,000	-17,000,000	-18,000,000	-19,000,000	7,000,000	-5,000,000	-1,000,000	5,000,000	-10,000,000	-11,000,000	13,000,000	-14,000,000	9,000,000
net increase in cash and equivalents																																			26,000,000	5,000,000	44,000,000	-1,926,000,000	-131,000,000	3,000,000	1,950,000,000	80,000,000	-208,000,000	-364,000,000	-329,000,000	51,000,000	840,000,000	-146,000,000	3,000,000	155,000,000							2,000,000					336,000,000	317,000,000	-96,000,000
cash and equivalents at beginning of the year
cash and equivalents at end of the year
december 31, 2016
gains on transactions
stock compensation tax withholding payments
march 31, 2019																								0	0	1,000,000
june 30, 2019																								0
september 30, 2019
operating leases																										3,000,000
transaction (gains) losses
settlement of net investment hedge																															0	0
short-term investments																																			0	0	0	47,000,000	5,000,000
net proceeds from climate transaction, including withholding tax refund
net cash (used by) provided from investing activities																															-78,000,000	-21,000,000	-7,000,000	-69,000,000
december 31, 2015
cash, cash equivalents, and restricted cash at beginning of the period																												0	0	709,000,000
cash, cash equivalents, and restricted cash at end of the period																												-86,000,000	2,000,000	526,000,000
gain on india operations repurchase																															0	0	0	-7,000,000
gains on divestitures and impairments
india operations repurchase																															0	0	0	-47,000,000
(gains) losses on divestitures and impairments																														-3,000,000		-2,000,000
gain on non-consolidated affiliate transactions																															-2,000,000	1,000,000
equity in net (income) loss of non-consolidated affiliates, net of dividends remitted
gain on climate transaction																																			0	0			8,000,000	0
loss on debt extinguishment																																							0	0			0	0										0	0
exercised warrants and stock options																																							16,000,000	5,000,000
december 31, 2014
stock-based compensation tax windfall
warrant exercises
distribution payable
acquisition of business
business divestiture
other comprehensive
payments for acquisition and divestiture of businesses
climate transaction withholding tax refund																																				0	0	356,000,000
loans to non-consolidated affiliates, net of repayments
net decrease in cash and equivalents																																2,000,000	42,000,000	-190,000,000																		-15,000,000	-27,000,000						65,000,000	43,000,000	-576,000,000
cash and equivalents at beginning of the period																																0	0	878,000,000		0	0	2,729,000,000		0	0	827,000,000
cash and equivalents at end of the period																																2,000,000	42,000,000	688,000,000		5,000,000	44,000,000	803,000,000		3,000,000	1,950,000,000	907,000,000
transformation initiatives																																					-1,000,000	2,000,000		14,000,000
loss on asset contribution
transaction exchange losses
accrued income taxes																																			-24,000,000	10,000,000	-6,000,000	-43,000,000	-129,000,000	-7,000,000			0	2,000,000	10,000,000	2,000,000	2,000,000	0	1,000,000	-57,000,000
capital expenditures																																	-15,000,000	-32,000,000	-19,000,000	-19,000,000	-12,000,000	-25,000,000	-36,000,000	-29,000,000	-67,000,000	-55,000,000	-131,000,000	-82,000,000	-75,000,000	-52,000,000	-105,000,000	-50,000,000	-51,000,000	-63,000,000	-44,000,000	-49,000,000	-53,000,000	-73,000,000	-59,000,000	25,000,000	-25,000,000	-64,000,000	-29,000,000	-33,000,000	-25,000,000	-144,000,000	-108,000,000	-82,000,000	-185,000,000		-238,000,000	-262,000,000
free cash flows
transaction exchange (gains) losses
loss on non-consolidated affiliate transaction																																		1,000,000
losses on other divestitures and impairments
pension settlement gain																																											2,000,000
net cash provided from (used by) investing activities																																						373,000,000	-173,000,000	-73,000,000
proceeds from issuance of debt, net of issuance costs																																											1,000,000	28,000,000			0	0	0	204,000,000	810,000,000	0	2,000,000	0	1,000,000		4,000,000	1,000,000	0	17,000,000	39,000,000
repurchase of long-term notes																																											0	0
december 31, 2013
gain on sale of non-consolidated affiliates																																								0
proceeds from climate transaction																																								0
net cash provided from investing activities																																				-19,000,000
transaction hedging and exchange losses
integration costs																																						1,000,000		-3,000,000	1,000,000	4,000,000
recoverable taxes
loans to non-consolidated affiliates
net proceeds from climate transaction
payments associated with business divestitures
transaction hedging and exchange (gains) losses
adjustments to reconcile net income to net cash (used by) provided from operating activities:
loan to non-consolidated affiliates																																						-8,000,000
proceeds from asset sales																																						3,000,000													8,000,000
transaction hedging and exchange																																						1,000,000
loan to non-consolidated affiliate																																							0	0	0	-10,000,000
december 31, 2012
asset impairments and losses on divestitures																																								1,000,000	2,000,000	14,000,000
proceeds from sale of non-consolidated affiliates																																								0
other business divestitures and acquisitions																																								5,000,000
benefit from losses on recoverable taxes
stock warrant and option exercises																																										10,000,000
transformation costs																																										10,000,000				10,000,000
gain on asset sales and business divestitures
cash payments associated with interiors divestiture
balance at december 31, 2011
common stock contribution to u.s. pension plans
balance at december 31, 2012
balance at december 31, 2013
balance at december 31, 2014
impairment of long-lived assets																																												15,000,000
equity in net income of affiliates, net of dividends remitted
cash and equivalents at beginning of period																																												0	0	1,677,000,000		0	0	825,000,000	0	0	723,000,000
cash and equivalents at end of period																																												-364,000,000	-329,000,000	1,728,000,000		-146,000,000	3,000,000	980,000,000	220,000,000	-15,000,000	696,000,000	-35,000,000	-81,000,000	-13,000,000	964,000,000		65,000,000	43,000,000	604,000,000			-96,000,000
purchase price
cash acquired
purchase price net of cash acquired
assets acquired:
property and equipment																																																				-2,000,000	37,000,000
contractually reimbursable engineering costs
intangible assets
other assets acquired
total assets acquired
liabilities assumed:
other liabilities assumed
total liabilities assumed
non-controlling interests
total purchase price allocation
assets																																																				0	2,012,000,000
cash and equivalents
restricted cash
other assets																																																				1,000,000	5,000,000
total assets held for sale
restructuring expenses																																														2,000,000
asset impairments																																																-5,000,000	9,000,000	2,000,000												30,000,000	0	0
gain on yanfeng transactions and sale of other joint ventures
payments to acquire interests in joint venture
cash acquired in consolidation of yfve
joint venture deconsolidation
cash restriction																																																						-1,000,000	0			-31,000,000	-7,000,000	68,000,000	-163,000,000
proceeds from rights offering, net of issuance costs
balance at december 31, 2010
deconsolidation
operating
investing
proceeds from business divestitures and asset sales																																																0	22,000,000	17,000,000
financing
payments to repurchase common stock																																																-125,000,000	0	-125,000,000
sales																																																-94,000,000	-13,000,000	139,000,000
cost of sales																																																-85,000,000	-10,000,000	123,000,000
gross margin																																																-9,000,000	-3,000,000	16,000,000
selling, general and administrative expenses																																																-2,000,000	0	3,000,000
interest expense																																																0
other income																																																0	-1,000,000	2,000,000
income from discontinued operations before income taxes																																																-2,000,000	-12,000,000	9,000,000
benefit from income taxes																																																		6,000,000
income from discontinued operations, net of tax																																																-4,000,000	-4,000,000	3,000,000
benefit for income taxes
pension and opeb
reorganization items																																																									30,000,000	30,000,000
payments on dip facility, net of issuance costs
balance at january 1, 2010 - predecessor
reorganization and fresh-start adjustments
balance at october 1, 2010 - successor
balance at december 31, 2010 - successor
balance at december 31, 2011 - successor
common stock contribution to u.s pension plans
balance at december 31, 2012 - successor
proceeds from business divestitures
rights offering fees																																																							0
other incomes
net income from discontinued operations attributable to visteon corporation
definite-lived intangibles																																																				0	5,000,000
deconsolidation gains
income taxes deferred and payable																																																														22,000,000
cash associated with deconsolidations
acquisitions of joint venture interests
proceeds from divestitures and asset sales																																																										64,000,000	1,000,000
proceeds from (payments on) dip facility, net of issuance costs
balance at january 1, 2009 - predecessor
foreign currency translation
benefit plans
comprehensive income
balance at december 31, 2009 - predecessor
reorganization and fresh-start related adjustments
reorganization expense
asset impairments and loss on sale of assets
other assets and liabilities																																																							-71,000,000		10,000,000		26,000,000	45,000,000	-150,000,000			10,000,000
other, including proceeds from divestitures and asset sales																																																							-7,000,000
cash and equivalents at beginning of year																																																									962,000,000	0	0	0	1,180,000,000	0	0	0
professional fees
other direct costs
cash payments for reorganization expenses
reorganization expenses
asset impairment and loss on sale of assets
note 1.
loss on sale of assets
deconsolidation gain																																																										0	0	0	-95,000,000
asset impairments and other (gains) and losses
investments in joint ventures
cash associated with deconsolidation and other
repurchase of unsecured debt securities																																																																0		0
item 8.
opeb and pension amortization and curtailment																																																									-240,000,000
opeb reinstatement
asset impairments and loss on divestitures																																																									21,000,000
cash associated with deconsolidation																																																											0	0	-11,000,000
increase in restricted cash																																																									-2,000,000
other, including overdrafts																																																										-6,000,000
adjustments to reconcile net income to net cash used by operating activities:
other, including proceeds from asset sales and divestitures																																																									1,000,000
other, including book overdrafts																																																									-1,000,000			-2,000,000	-56,000,000	-18,000,000	6,000,000	4,000,000	57,000,000	51,000,000
non-cash tax items																																																														-37,000,000
accounts receivable and retained interests																																																														121,000,000
postretirement benefits other than pensions																																																														-2,000,000
acquisitions and investments in joint ventures																																																																	-1,000,000
proceeds from dip facility, net of issuance costs
cash and equivalents at end of year
gain on asset sales																																																											3,000,000
asset impairments and loss on divestiture
proceeds from divestiture and asset sales																																																													2,000,000
non-cash postretirement benefits																																																														-44,000,000
escrow receivable																																																														2,000,000
maturity/repurchase of unsecured debt securities
(gain) loss on asset sales
gain on ach transactions
net cash proceeds from ach transactions
other, including proceeds from asset disposals																																																																	37,000,000
cash paid for:
interest
income taxes paid, net of refunds
extraordinary item, net of tax																																																															0	0
debt extinguishment gain
change in receivables sold																																																															21,000,000
other investments
proceeds from debt, net of issuance costs																																																																6,000,000
postretirement benefit relief																																																															0	0
proceeds from sales of assets																																																																7,000,000
product sales
services revenues
(gain)/loss on debt extinguishment
commercial paper repayments
gain on debt extinguishment
cash provided from (used by) operating activities
cash provided from (used by) investing activities
proceeds from asset disposals
cash provided from (used by) financing activities
other short-term debt																																																																	48,000,000	10,000,000
proceeds from issuance of other debt, net of issuance costs																																																																	10,000,000	28,000,000
principal payments on other debt																																																																	-30,000,000	0	0	-118,000,000
purchases of securities																																																																			0	-24,000,000
sales and maturities of securities																																																																		8,000,000	0	141,000,000
maturity/ repurchase of unsecured debt securities																																																																	0
treasury stock activity																																																																	0
balance at january 1, 2003
comprehensive income, net of tax
minimum pension liability
deferred stock-based compensation
amortization and adjustment of deferred stock-based compensation
balance at december 31, 2003
shares issued for stock options exercised
balance at december 31, 2004
stock warrants
balance at december 31, 2005
cash and cash equivalents at january 1																																																																		0	0	0
cash flows from operating activities																																																																		191,000,000	253,000,000	733,000,000
asset impairment charges
earnings of affiliated companies less than dividends remitted
sale of receivables
cash flows from investing activities
deposit on transferred business
cash flows from financing activities
net increase in cash and cash equivalents
cash and cash equivalents at september 30
cash and cash equivalents at june 30
earnings of affiliated companies less than (in excess of) dividends remitted
cash and cash equivalents at march 31
commercial paper (repayments)
purchase of treasury stock																																																																		0	0	-9,000,000
cash and cash equivalents at december 31
cash flows from investing activities capital expenditures
net decrease in cash and cash equivalents
commercial paper (repayments) issuances																																																																				-88,000,000
proceeds from issuance of other debt																																																																			-118,000,000	22,000,000
commercial paper
payments on short-term debt
proceeds from issuance of short-term debt
cash and cash equivalents at january 1
cash flows from operating activities
commercial paper issuances
cash and cash equivalents at march 31

We provide you with 20 years of cash flow statements for Visteon stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Visteon stock. Explore the full financial landscape of Visteon stock with our expertly curated income statements.

The information provided in this report about Visteon stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.